company
as of 2026-07-01King's College London
at a glance
46 trials sponsored · 52 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
52 assets
AmisulprideCannabidiolClozapineMinocyclineOlanzapineRisperidoneAUT00206Anxiety interventionAscorbic Acid 50 Mg Oral TabletCBT for Depersonalization/DerealizationCCP InterventionCitalopramCognitive Remediation TherapyCompassion Focused TherapyDelta-9-THCDiazepam 5 Mg Oral TabletDiroximel fumarate (DRF)Focus groupGRASPGlyceryl TrinitrateGuided Autobiographical Memory RecallHealth Champions interventionHigh Intensity Interval Training (HIIT)Imagery RescriptingIntegrated mental health in primary careJumping to conclusions interventionKetamineLevetiracetamLink work interventionMANOEUVRE therapyMRI scanN-acetylcysteineNatalizumabNovel Mobile AppPET-MR scanPersonalised medication advice based on pharmacogenetic testingPhysical Health PlanPsychiatric nurse-led specialist carePsychosocial interventionReducing Stigma among Healthcare Providers (RESHAPE)RiluzoleSMS reminderSelf-esteem interventionSelf-stigma interventionSloMoSocial Cognition GroupSodium Nitroprusside infusionStandard careVirtual reality assisted CBTdisposable electronic cigarettesmental health Gap Action Programmenon-invasive brain stimulation
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
drugsmall molecule
Cannabidiol
drugsmall molecule
Clozapine
drugsmall molecule
Minocycline
drugsmall molecule
Olanzapine
drugsmall molecule
Risperidone
drugsmall molecule
AUT00206
drugsmall molecule
Anxiety intervention
drugBEHAVIORAL